Related Experiment Video

Updated: Jul 19, 2026

An Optimized Single-Molecule Pull-Down Assay for Quantification of Protein Phosphorylation
07:45

An Optimized Single-Molecule Pull-Down Assay for Quantification of Protein Phosphorylation

Published on: June 6, 2022

Simulation and sensitivity analysis of phosphorylation of EGFR signal transduction pathway in PC12 cell model

C V Suresh Babu1, S Yoon, H S Nam

  • 1Bioanalysis and Biotransformation Research Center, Korea Institute of Science and Technology, Cheongryang, Seoul.

Systems Biology
|October 21, 2006
PubMed

Insights

This study presents a kinetic model of the mitogen-activated protein kinases (MAPKs) pathway activated by epidermal growth factor receptor (EGFR). The model accurately reflects experimental data, offering a quantitative framework for EGFR signaling.

Area of Science:

  • Cellular signaling
  • Biochemical kinetics
  • Systems biology

Background:

  • The epidermal growth factor receptor (EGFR) pathway activates the mitogen-activated protein kinases (MAPKs) cascade, crucial for cell function.
  • Understanding the complex interactions within the MAPK network is essential.

Purpose of the Study:

  • To develop a kinetic model of the MAPK pathway downstream of EGFR.
  • To quantitatively analyze EGFR-induced signaling events.

Main Methods:

  • Utilized a biochemical simulator to construct a kinetic model.
  • The model incorporates 30 signaling events and 29 molecules.
  • Compared simulation time-course data with experimental results from PC12 cells.

Main Results:

  • The kinetic model accurately predicted EGFR-induced protein activation.
  • Simulations provided extensive data on signaling component kinetics.
  • Model predictions showed good correspondence with experimental observations.

Conclusions:

  • The developed kinetic model provides a quantitative framework for the EGFR signaling network.
  • This approach allows for detailed analysis of signaling pathway dynamics.
  • The study validates the model's accuracy through experimental comparison.

More Related Videos

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

Development and Application of Rapamycin-regulated Tyrosine Phosphatases06:56

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Published on: September 6, 2024

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...